gallstones glp-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications Do Diabetes Medicines Like GLP-1

The Advanced Hack: Microneedling + Copper Peptides Microneedling (using a derma roller or stamp with 0.5mm to 1.0mm needles) creates tiny micro-punctures in the scalp

Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study.Front Endocrinol (Lausanne)

Ive struggled with weight loss for years

For patients interested in participating in research , the following resources may be helpful: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) search for Parkinson's and GLP-1 trials Parkinson's UK (www.parkinsons.org.uk) information on current research and trial opportunities When to contact your GP or specialist : If you have Parkinson's disease and diabetes, and wish to discuss whether a GLP-1 receptor agonist is appropriate for your diabetes management If you experience new or worsening symptoms whilst taking any medication If you are interested in clinical trial participationyour neurologist can advise on suitable studies Seek urgent medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Signs of dehydration (extreme thirst, dark urine, dizziness) Allergic reaction (rash, swelling, difficulty breathing) Patients should never start, stop, or modify medications without medical supervision

Headache: Some people may experience headaches

They slow the movement of food through the stomach, so people stay satisfied for longer after a meal